Skip to main content
. Author manuscript; available in PMC: 2014 Mar 14.
Published in final edited form as: Circulation. 2009 Jul 13;120(4):326–333. doi: 10.1161/CIRCULATIONAHA.109.849885

Table 1.

Demographic Characteristics

Patient Characteristic Implanted Patients (n=30) Nonimplanted Patients (n=18) P
Age, mean (SD), y 64 (9) 65 (15) 0.75
Male, n (%) 26 (87) 14 (78) 0.45
NYHA class, n (%) 0.86
 I 0/30 (0) 0/18 (0)
 II 6/30 (20) 3/18 (17)
 III 22/30 (73) 15/18 (83)
 IV 2/30 (7) 0/18 (0)
6 MWD, mean (SD), m 307 (87) 284 (104) 0.42
Medical history, n/N (%)
 COPD 6/28 (21) 5/17 (29) 0.72
 CAD 25/30 (83) 10/18 (56) 0.05
 CABG 11/30 (85) 6/18 (56) 0.55
HF admissions in past 12 mo, mean (SD), n 1.2 (1.5) 1.5 (1.7) 0.57
Medications, n (%)
 Diuretics 25/30 (83) 17/18 (94) 0.39
 ACE inhibitor/ARB 27/30 (90) 18/18 (100) 0.28
β-Blocker 29/30 (97) 17/18 (94) 1.00
Echocardiographic parameters, mean (SD)
 LVEDD, cm 6.7 (0.75) 6.6 (0.94) 0.83
 Mitral annular diameter, cm 4.2 (0.4) 3.96 (0.45) 0.06
 LVEF, mean (SD), % 30 (8) 29 (8) 0.59

6 MWD indicates 6-minute walk distance; COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; CABG, coronary artery bypass graft; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; LVEDD, left ventricular end-diastolic diameter; and LVEF, left ventricular ejection fraction.